共 156 条
[1]
Yancy CW(2013)2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines Circulation 128 e240-e327
[2]
Jessup M(2001)Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial Lancet 357 1385-1390
[3]
Bozkurt B(2003)Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial Lancet 362 7-13
[4]
Butler J(1994)Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial J Am Coll Cardiol 23 943-950
[5]
Casey DE(1995)Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure Circulation 92 1499-1506
[6]
Drazner MH(1993)Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in dilated cardiomyopathy (MDC) trial study group Lancet 342 1441-1446
[7]
Dargie HJ(2002)Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study Circulation 106 2194-2199
[8]
Poole-Wilson PA(1996)The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group N Engl J Med 334 1349-1355
[9]
Swedberg K(2012)ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement J Am Coll Cardiol 59 1812-1832
[10]
Cleland JG(2005)Risk-treatment mismatch in the pharmacotherapy of heart failure JAMA 294 1240-1247